INVENTIVA (EPA:IVA) | Finanzwire

PRESS RELEASE

published on 11/20/2024 at 22:00, 1 year 5 months ago

Combined General Meeting of December 11, 2024 - Availability of the preparatory documents
Inventiva announces availability of preparatory documents for Combined General Meeting on December 11, 2024. Shareholders can participate in person or request documents electronically. Detailed resolutions and meeting information provided

Shareholders Resolutions Preparatory Documents Combined General Meeting Inventiva
BRIEF

published on 11/15/2024 at 22:05, 1 year 5 months ago

Inventiva Reveals Promising Phase 2 Study Results of Lanifibranor and Empagliflozin Combination

Phase 2 Study Clinical Trial Results Inventiva Lanifibranor MASH And T2D
PRESS RELEASE

published on 11/15/2024 at 22:00, 1 year 5 months ago

Inventiva will present data from the final analysis of the Phase 2 study evaluating the combination of lanifibranor with empagliflozin in patients with MASH and T2D at the AASLD The Liver Meeting® late-breaker session
Inventiva presents positive results from Phase 2 study on lanifibranor and empagliflozin combination therapy for MASH and T2D patients at AASLD The Liver Meeting® 2024

Inventiva MASH Lanifibranor Empagliflozin T2D
BRIEF

published on 10/30/2024 at 21:05, 1 year 6 months ago

Inventiva's Stock Rises Following Positive Update on Lanifibranor Trial

Inventiva MASH Lanifibranor NATiV3 Clinical Trial DMC Recommendation
PRESS RELEASE

published on 10/30/2024 at 21:00, 1 year 6 months ago

Inventiva announces the positive recommendation of the fifth DMC of the NATiV3 Phase 3 clinical trial with lanifibranor in patients with MASH
Inventiva receives positive recommendation from fifth DMC review for lanifibranor in MASH Phase 3 trial, confirming good safety profile

Safety Data Inventiva MASH Lanifibranor Positive Recommendation
BRIEF

published on 10/23/2024 at 11:38, 1 year 6 months ago

Invus Public Equities exceeds thresholds at Inventiva

Voting Rights Capital Increase Crossing Thresholds Inventiva Invus Public Equities
BRIEF

published on 10/23/2024 at 11:36, 1 year 6 months ago

BVF Partners Crosses Thresholds in Inventiva's Capital

Voting Rights Capital Increase Crossing Thresholds Inventiva BVF Partners
BRIEF

published on 10/21/2024 at 14:35, 1 year 6 months ago

Inventiva presents an abstract at the Liver Meeting™ 2024

Clinical Trial Inventiva NASH Lanifibranor Liver Meeting™
PRESS RELEASE

published on 10/21/2024 at 14:30, 1 year 6 months ago

Inventiva announces a late breaker abstract from LEGEND, Phase 2 trial, evaluating lanifibranor in combination with empagliflozin in MASH at the AASLD The Liver Meeting® 2024
Inventiva announces late breaker abstract from LEGEND Phase 2 trial evaluating lanifibranor with empagliflozin in MASH at AASLD The Liver Meeting® 2024

Inventiva MASH Lanifibranor LEGEND Phase 2 Empagliflozin
BRIEF

published on 10/14/2024 at 19:50, 1 year 6 months ago

Inventiva obtains AMF approval for its financing prospectus

AMF Funding Inventiva Steatohepatitis Drugs

Published on 05/01/2026 at 04:00, 2 hours 25 minutes ago

Jericho Energy Ventures Announces Short Delay in Filing of 2025 Annual Financial Statements
Published on 05/01/2026 at 03:25, 3 hours ago

McEwen Inc. and Golden Lake Exploration Inc. Announce Closing of Arrangement
Published on 05/01/2026 at 02:55, 3 hours 30 minutes ago

GLG Life Tech Corporation Reports 2025 Annual & Fourth Quarter Financial Results
Published on 05/01/2026 at 01:00, 5 hours 25 minutes ago

PPX Mining Announces Grant of Stock Options, Restricted Share Units and Deferred Share Units
Published on 05/01/2026 at 00:45, 5 hours 40 minutes ago

Inventus Announces Closing of $2.5 Million Non-Brokered Flow-Through Financing

View all ACCESSWIRE

Published on 04/30/2026 at 23:39, 6 hours 46 minutes ago

Anemoi International Ltd: Final Results For Year Ended 31 December 2025
Published on 04/30/2026 at 22:35, 7 hours 50 minutes ago

Curaleaf Completes Buyout of Remaining Stake in Germany's Four 20 Pharma
Published on 04/30/2026 at 22:04, 8 hours 21 minutes ago

Interim individual financial statements for the period ending on March 31, 2026 of Sirma Group Holding JSC
Published on 04/30/2026 at 19:00, 11 hours 25 minutes ago

DOUGLAS Group grows sales in Q2 and updates full-year guidance on adjusted EBITDA
Published on 04/30/2026 at 19:00, 11 hours 25 minutes ago

BioVersys announces approval of all Board Proposals at Annual General Meeting of Shareholders

View all EQS

Published on 04/30/2026 at 20:00, 10 hours 24 minutes ago

AMA Corp PLC : FY 2025 Earnings & Q1 2026 Revenue
Published on 04/30/2026 at 19:16, 11 hours 9 minutes ago

AXA announces the results of its Shareholders' Meeting
Published on 04/30/2026 at 19:00, 11 hours 25 minutes ago

Capital increase through exercise of subscription rights
Published on 04/30/2026 at 18:10, 12 hours 15 minutes ago

Minutes of the Combined General Meeting held on April 30, 2026
Published on 04/30/2026 at 18:00, 12 hours 25 minutes ago

TF1 Q1 2026 results - Press release

View all LES ECHOS COMFI WIRE

News